Tombak, A. Et Al. 2019. Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Florida, United States Of America).

Tombak, A., Tanrikulu, F. P., Durusoy, S. S., GÜRKAN, E., KAYA, E., Umit, E. G., ... Yavasoglu, I.(2019). Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study . 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America

Tombak, Anil Et Al. "Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study," 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2019

Tombak, Anil Et Al. "Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America, 2019

Tombak, A. Et Al. (2019) . "Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America.

@conferencepaper{conferencepaper, author={Anil Tombak Et Al. }, title={Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study}, congress name={61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2019}}